Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers

Drug and Alcohol Review

Volumn 26, Issue 4, 2007, Pages 429-433

  Paul, Christine L ^a   Tzelepis, Flora ^a   Walsh, Raoul A ^a   Turner, Richard ^b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Community Pharmacist ^*  (Australia)

^c Centre for Health Research and Psycho oncology ^*

Author keywords

Bupropion; Nicotine replacement therapy; Pharmacist; Smoking cessation; Tobacco

Indexed keywords

AMFEBUTAMONE; DOPAMINE UPTAKE INHIBITOR; NICOTINE; NICOTINIC AGENT;

ADULT; ARTICLE; AUSTRALIA; FEMALE; HEALTH EDUCATION; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; NICOTINE; NICOTINIC AGONISTS; PHARMACIES; PHARMACISTS; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT;

EID: 34250334560     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701373966     Document Type: Article

References (25)

1. World Health Organisation. The World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organisation, 2002.
2. Jacobs Jr DR, Adachi H, Mulder I, et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999;159:733-40.
3. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA 1999;281:72-6.
4. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, 2000.
5. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;Issue 3.
6. Walsh RA, Penman AG. The effectiveness of nicotine replacement therapy over-the-counter [Editorial]. Drug Alcohol Rev 2000; 19:243-7.
7. Sonderskov J, Olsen J, Sabroe S, Meillier L, Overvad K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997;145:309-18.
8. Sinclair HK, Bond CM, Lennox AS, Taylor RJ, Winfield AJ. Nicotine replacement therapies: smoking cessation out-comes in a pharmacy setting in Scotland. Tob Control 1995;4:338-43.
9. Doran CM, Shakeshaft AP, Gates JA, Fawcett JE, Mattick RP. Current prescribing patterns of bupropion in Australia. Med J Aust 2002;177:162.
10. Burton B. Australia turns to drug company representatives to cut prescribing. BMJ 2002;324:1234a.
11. Shiffinan S, Rolf CN, Hellebusch SJ, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002;97:505-16.
12. Thorndike AN, Biener L, Rigotti NA. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2002;92:437.
13. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA2002;288:1260-4.
14. Chapman S, Borland R. Advertising of nicotine replacement therapy: has it promoted more smoking cessation? Smith Kline Beecham Consumer Healthcare 1999;2-7.
15. Paul C, Walsh RA, Girgis A. Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust NZ J Public Health 2003;27:491-5.
16. Hassard K, ed. Australia's National Tobacco Campaign evaluation: report vol 1. Canberra: Commonwealth Department of Health and Aged Care, 1999.
17. Hudmon K, Hemberger K, Corelli R, et al. The pharmacist's role in smoking cessation counselling: perceptions of users of non-prescription nicotine replacement therapy. J Am Pharm Assoc 2003;43:573-82.
18. Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan FT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control 1998;7:253-61.
19. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction 2001;96:325-31.
20. Carroll P, Fois R, Sarson D, Flynn J. A community pharmacy-based smoking cessation program using transdermal nicotine replacement therapy-actions and out-comes. Aust Pharm 2000;19:51-5.
21. Couchenour RL, Denham AZ, Simpson KN, Lahoz MR, Carson DS. Smoking cessation activities in South Carolina community pharmacies. J Am Pharm Assoc 2000;40: 828-31.
22. Williams DM, Newsom JF, Brock TP. An evaluation of smoking cessation-related activities by pharmacists. J Am Pharm Assoc 2000;40:366-70.
23. O'Loughlin J, Masson P, Dery V, Fagnan D. The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 1999;28:324-31.
24. Paul CL, Walsh RA, Tzelepis F. A monetary incentive increases postal survey response rates for pharmacists. J Epidemiol Commun Health 2005;59:1099-101.
25. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000;321:355-8.